Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-036018

ARIAD PHARMACEUTICALS INC · ARIA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Harvey J M D Berger
Officer — Chairman & CEO · Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 5, 2016 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 31, 2015M36,000$0.00A1,449,992D
Common StockDec 31, 2015F16,992$6.25D1,433,000D
Common StockDec 31, 2015M345,000$0.00A1,778,000D
Common StockDec 31, 2015F162,841$6.25D1,615,159D
Common StockDec 31, 2015M47,500$0.00A1,662,659D
Common StockDec 31, 2015F22,420$6.25D1,640,239D
Common StockDec 31, 2015M174,000$0.00A1,814,239D
Common StockDec 31, 2015F82,128$6.25D1,732,111D
Common Stockholding———246,054IDaughter
Common Stockholding———248,745IDaughter
Common StockF6holding———1,864,286IOcean Capital Partners, Llc
Common Stockholding———245,251IWife

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF7,F8—Dec 31, 2015M36,000D——Common Stock36,0000D
Restricted Stock UnitsF7,F8—Dec 31, 2015M345,000D——Common Stock345,0000D
Performance stock unitF9,F8—Dec 31, 2015M47,500D——Common Stock47,5000D
Restricted Stock UnitsF7,F8—Dec 31, 2015M174,000D——Common Stock174,0000D

Explanation of responses